Charles B O'Keeffe Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Charles B O'Keeffe is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 732,470 shares of CPRX, which is worth approximately $15.8 Million. The most recent transaction as insider was on Feb 14, 2025, when has been sold 4,000 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 732K

6.82% 3M change

6.82% 12M change

Total Value Held $15.8 Million

Charles B O'Keeffe Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	BUY Exercise of conversion of derivative security	-	4,000 Added 0.54%	732,470 Common Stock, par valu...
Dec 27 2024	BUY Exercise of conversion of derivative security	-	1,333 Added 0.18%	728,470 Common Stock, par valu...
Dec 10 2024	BUY Exercise of conversion of derivative security	$160,400 $4.01 p/Share	40,000 Added 5.21%	727,137 Common Stock, par valu...
Dec 09 2024	BUY Exercise of conversion of derivative security	-	1,413 Added 0.21%	687,137 Common Stock, par valu...
Feb 15 2024	BUY Exercise of conversion of derivative security	-	4,000 Added 0.58%	685,724 Common Stock, par valu...
Jan 02 2024	BUY Exercise of conversion of derivative security	$67,800 $1.13 p/Share	60,000 Added 8.09%	681,724 Common Stock, par valu...
Dec 27 2023	BUY Exercise of conversion of derivative security	-	1,333 Added 0.21%	621,724 Common Stock, par valu...
Feb 15 2023	BUY Exercise of conversion of derivative security	-	4,000 Added 0.64%	620,391 Common Stock, par valu...
Jan 24 2023	BUY Exercise of conversion of derivative security	$39,500 $0.79 p/Share	50,000 Added 7.5%	616,391 Common Stock, par valu...
Dec 06 2022	BUY Exercise of conversion of derivative security	-	1,334 Added 0.23%	566,391 Common Stock, par valu...
Nov 15 2022	BUY Open market or private sale	$1,411,279 $16.04 p/Share	87,985 Added 13.47%	565,057 Common Stock, par valu...
Aug 18 2022	BUY Exercise of conversion of derivative security	$101,200 $2.53 p/Share	40,000 Added 5.77%	653,042 Common Stock, par valu...
Dec 03 2021	BUY Exercise of conversion of derivative security	-	1,333 Added 0.22%	613,042 Common Stock, par valu...
Aug 16 2021	BUY Exercise of conversion of derivative security	$156,000 $3.12 p/Share	50,000 Added 7.56%	611,709 Common Stock, par valu...
Dec 22 2020	BUY Exercise of conversion of derivative security	-	1,333 Added 0.24%	561,709 Common Stock, par valu...
Sep 30 2020	BUY Open market or private purchase	$20,930 $2.99 p/Share	7,000 Added 1.23%	560,376 Common Stock, par valu...

CBO

Charles B O'Keeffe

Director

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account